The DOI matches its Crossref record.
Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor (MCAF/MCP‐1)
Abstract
We investigated the pathophysiological role of a potent macrophage (Mϕ) chemotactic cytokine (chemokine), monocyte chemotactic and activating factor/monocyte chemoattractant protein‐1 (MCAF/MCP‐1), in an animal model of crescentic glomerulonephritis. Administration of a small dose of nephrotoxic sera induced severe proliferative and necrotizing glomerulonephritis, with crescentic formation in the early phase and glomerulosclerosis in the later phase, in Wistar‐Kyoto rats. MCAF/MCP‐1 protein was detected immunohistochemically in glomeruli, vascular endothelial cells, and tubular epithelial cells in the early phase of injured kidney tissues but not in normal ones. Anti‐MCAF/MCP‐1 antibodies decreased the number of Mϕ in glomeruli, and prevented crescentic formation and the fusion of epithelial cell foot process in nephritic rats, thereby decreasing the excreted amounts of protein to normal levels on days 3 and 6. Furthermore, anti‐MCAF/MCP‐1 antibodies remarkably reduced glomerulosclerosis and improved renal dysfunction as well as proteinuria in the later phase (56 days). These results indicate that MCAF/MCP‐1 essentially participates in the impairment of renal functions associated with crescentic glomerulonephritis by recruiting and activating Mϕ.—Wada, T., Yokoyama, H., Furuichi, K., Kobayashi, K.‐i., Harada, K., Naruto, M., Su, S.‐B., Akiyama, M., Mukaida, N., Matsushima, K. Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor (MCAF/MCP‐1). FASEB J. 10, 1418‐1425 (1996)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Oral tolerance: immune mechanisms and treatment of autoimmune diseases
Weiner, H. L. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01053-0 · Cited by 731
SEGERER, S., NELSON, P. J., & SCHLO[Combining Diaeresis]NDORFF, D. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v111152 · Cited by 502
MCP-1: Chemoattractant with a role beyond immunity: A review
Yadav, A., Saini, V., & Arora, S. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.07.006 · Cited by 488
Mukaida, N., Harada, A., & Matsushima, K. (1998) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00022-1 · Cited by 401
Self-citationLeukocyte Recruitment and Vascular Injury in Diabetic Nephropathy
Galkina, E., & Ley, K. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005080859 · Cited by 376
Metadata
- Authors
- Wada, T., Yokoyama, H., Furuichi, K., Kobayashi, K., Harada, K., Naruto, M., Su, S., Akiyama, M., Mukaida, N., & Matsushima, K.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 1996-10
- Volume
- 10
- Issue
- 12
- Pages
- 1418-1425
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1779615637
- Cited by
- 210
- References
- 0
- FWCI
- 13.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor (MCAF/MCP‐1). https://app.cochat.ai/papers/10.1096/fasebj.10.12.8903512
- The paper
- Wada, T., Yokoyama, H., Furuichi, K., Kobayashi, K., Harada, K., Naruto, M., Su, S., Akiyama, M., Mukaida, N., & Matsushima, K. (1996). Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor (MCAF/MCP‐1). The FASEB Journal. https://doi.org/10.1096/fasebj.10.12.8903512
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.